-
Light at the End of the Tunnel for ASPS Patients
Immunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose
-
CAR T-cell Therapy: Understanding the Warning and the Risks
The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
Overcoming Lung Cancer Stigma With Understanding
Shirley Muñoz wants to use her experience as a younger lung cancer patient to break down barriers to care for her community through translation and advocacy.
by Cameron Walker
-
Real-world Outcomes in Multiple Myeloma
Study shines a light on the differences in outcomes between clinical trial patients with multiple myeloma and those receiving cancer treatment in their community.
by Sandra Gordon
-
Some Breast Cancer Patients May Safely Skip Radiation
Three presentations at SABCS in December find that it may be safe in certain cases for people with breast cancer to go without radiation.
by Cancer Research Catalyst
-
Emerging Treatments for Brain Metastases in Breast Cancer
SABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
-
Forward Look
CDK4/6 Inhibitors in Early-stage Breast CancerA mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
by Darcy Lewis
-
Forward Look
A Less Radical ApproachSome women with early-stage cervical cancer may be able to receive simple hysterectomy, which reduces the risk of complications.
by Thomas Celona
-
Forward Look
Ultrasound Device Opens Blood-brain BarrierAn implantable device, along with an infusion of microbubbles, helps increase chemotherapy concentrations for brain cancer.
by Eric Fitzsimmons
-
Forward Look
The Lasting Benefit of Immune Checkpoint InhibitorsStudy suggests people with advanced lung cancer who have a sustained response to immunotherapy can safely stop treatment after two years.
by Lindsay Modglin
Cancer Talk
TIL Therapy Amplifies the Immune System’s Attack on Melanoma
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
Dealing With Immediate Medical Test ResultsPatients have been entitled to immediate access to medical records and test results for three years as a result of the Cures Act. It has changed how patients and doctors share information.
by Taneia Surles
Empowering Pediatric Cancer PatientsAfter twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.
by Suzanne McBride
Light at the End of the Tunnel for ASPS PatientsImmunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose